Sibutramine in the treatment of obesity in women

Abstract

We studied 30 obese women aged 43.5±3.2 years. All patients, depending on the received therapy, were divided into two groups: 1 group consisted of 15 patients receiving sibutramine, 2 group consisted of women receiving sibutramine and Metformin. All women were measured weight, height, then calculated body mass index, waist (W) and hip (H), also fasting blood sugar and 2 hours after eating, lipid spectrum, to eliminate hypothyroidism hormones TSH, free T3, free T4, antibodies to TPO. During the treatment of sibutramine with Metformin in combination led to a decrease in body weight in 15% of patients, sibutramine monotherapy was observed in 10%.